Skip to main content

Eli Lilly agrees to buy Waltham-based biotech Morphic in $3.2 billion deal

The company will pay $57 a share in cash for Morphic, or 79 percent more than the closing price Friday.

Vertex to stay at Fan Pier headquarters after all
Vertex, the most valuable homegrown biotech in the state, had for months been considering vacating its 1.1 million-square-foot headquarters in the Seaport neighborhood.

AbbVie to buy Cambridge biotech Celsius for $250 million
Privately held Celsius has developed an experimental drug for inflammatory bowel disease.

Moderna just opened its new headquarters in Cambridge. Take a look inside.
The company's COVID vaccine put it on the map, and it hopes bringing its work force together at the new site spurs further discoveries.

Ginkgo Bioworks plans to lay off more than a third of its workers
Based on the headcount reported by the company for the end of last year, at least 400 workers could lose their jobs.

Alnylam shares surge as biotech trumpets positive trial results of heart disease drug
Shares of Alnylam climbed at least 37 percent in pre-market trading Monday morning on the prospect of a drug that could generate billions of dollars for the Cambridge company.

Sarepta jumps on broad approval for muscular dystrophy drug
Sarepta's gene therapy received expanded US approval to include more children with a deadly muscle disease.

Ginkgo Bioworks lays off 158 employees, with more to come
The once-fast-growing life sciences firm is slashing expenses amid financial woes.

More Life Sciences Headlines

RI BUSINESS

R.I. Life Science Hub picks interim president

Patrice Milos, who has 30 years of experience in the life science industry and was a founding member of RI Bio, will make $25,000 a month as the board searches for a permanent CEO.

Moderna’s flu-COVID combo shot hits goal in late-stage trial

The result brings the Cambridge-based company one step closer to a more convenient jab that could help combat vaccine fatigue.

Cow burps are a major source of methane emissions. A Boston startup is working on a vaccine to fix that.

The methane emitted by the world’s billion-plus belching cattle has roughly the same impact on the climate as all the passenger vehicles on the planet, says Colin South, chief executive of ArkeaBio.

Former Takeda Pharmaceutical employee pleads guilty to stealing $2.3 million

Priya Bhambi, 40, of Brookline, pleaded guilty in US District Court in Boston to one count of conspiracy to commit wire fraud and three counts of wire fraud, prosecutors said Thursday.

Moderna’s vaccine for RSV gets FDA approval for people 60 and older

The approval was welcome news for Cambridge-based Moderna, which has desperately needed a money-making follow-up to its COVID vaccine, Spikevax.

Gates Medical Research Institute in Cambridge names new head

Novartis veteran Patrice Matchaba will succeed Emilio Emini, who recently announced that he will retire on June 30.

Tell us: Are you a current or former Takeda employee? We want to hear about it.

Were you surprised by the size of the layoffs? How do you think they will affect what Takeda does in Massachusetts?

Drug giant Takeda plans more than 640 layoffs in Massachusetts

The state's largest drug maker by headcount confirmed Friday that it plans to lay off hundreds of local employees between early July and next March.